Caucasian
Item
caucasian
boolean
C0043157 (UMLS CUI [1])
Age
Item
>18 years of age
boolean
C0001779 (UMLS CUI [1])
Onset of Warfarin therapy
Item
included in the study at the onset of warfarin treatment
boolean
C0332162 (UMLS CUI [1,1])
C4303340 (UMLS CUI [1,2])
Target INR Atrial Fibrillation | Target INR Venous Thrombosis | Target INR Pulmonary Embolism | Target INR Heart Valve Prosthesis
Item
target inr (2-3 for atrial fibrillation, vein thrombosis, pulmonary embolism and 2.5-3.5 for prosthetic heart valves)
boolean
C1272307 (UMLS CUI [1,1])
C0004238 (UMLS CUI [1,2])
C1272307 (UMLS CUI [2,1])
C0042487 (UMLS CUI [2,2])
C1272307 (UMLS CUI [3,1])
C0034065 (UMLS CUI [3,2])
C1272307 (UMLS CUI [4,1])
C0018825 (UMLS CUI [4,2])
Indication Warfarin therapy
Item
standard indications for warfarin treatment
boolean
C3146298 (UMLS CUI [1,1])
C4303340 (UMLS CUI [1,2])
Population Group Except Caucasian
Item
non-caucasian
boolean
C1257890 (UMLS CUI [1,1])
C0332300 (UMLS CUI [1,2])
C0043157 (UMLS CUI [1,3])
Liver disease
Item
clinical significant liver affection
boolean
C0023895 (UMLS CUI [1])
Heart failure New York Heart Association Classification
Item
heart failure, nyha class iii-iv
boolean
C0018801 (UMLS CUI [1,1])
C1275491 (UMLS CUI [1,2])
Protocol Compliance Unable
Item
non-compliant - not able to accomplish protocol demands
boolean
C0525058 (UMLS CUI [1,1])
C1299582 (UMLS CUI [1,2])
Informed Consent Unable
Item
not able to give informed consent
boolean
C0021430 (UMLS CUI [1,1])
C1299582 (UMLS CUI [1,2])
Antibiotic therapy Long-term
Item
long-term antibiotic therapy
boolean
C0338237 (UMLS CUI [1,1])
C0443252 (UMLS CUI [1,2])
Malabsorption | Inflammatory Bowel Disease
Item
malabsorption conditions and inflammatory bowel disease
boolean
C0024523 (UMLS CUI [1])
C0021390 (UMLS CUI [2])